Literature DB >> 9154871

Quantification of idiopathic pulmonary fibrosis using computed tomography and histology.

H O Coxson1, J C Hogg, J R Mayo, H Behzad, K P Whittall, D A Schwartz, P G Hartley, J R Galvin, J S Wilson, G W Hunninghake.   

Abstract

We used computed tomography (CT) and histologic analysis to quantify lung structure in idiopathic pulmonary fibrosis (IPF). CT scans were obtained from IPF and control patients and lung volumes were estimated from measurements of voxel size, and X-ray attenuation values of each voxel. Quantitative estimates of lung structure were obtained from biopsies obtained from diseased and normal CT regions using stereologic methods. CT density was used to calculate the proportion of tissue and air, and this value was used to correct the biopsy specimens to the level of inflation during the CT scan. The data show that IPF is associated with a reduction in airspace volume with no change in tissue volume or weight compared with control lungs. Lung surface area decreased two-thirds (p < 0.001) and mean parenchymal thickness increased tenfold (p < 0.001). An exudate of fluid and cells was present in the airspace of the diseased lung regions and the number of inflammatory cells, collagen, and proteoglycans was increased per 100 g of tissue in IPF. We conclude that IPF reorganized lung tissue content causing a loss of airspace and surface area without increasing the total lung tissue.

Entities:  

Mesh:

Year:  1997        PMID: 9154871     DOI: 10.1164/ajrccm.155.5.9154871

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  27 in total

Review 1.  Quantitative pulmonary imaging using computed tomography and magnetic resonance imaging.

Authors:  George R Washko; Grace Parraga; Harvey O Coxson
Journal:  Respirology       Date:  2012-04       Impact factor: 6.424

2.  Selection of patients for lung volume reduction surgery using a power law analysis of the computed tomographic scan.

Authors:  H O Coxson; K P Whittall; Y Nakano; R M Rogers; F C Sciurba; R J Keenan; J C Hogg
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

Review 3.  The Microbiome and the Respiratory Tract.

Authors:  Robert P Dickson; John R Erb-Downward; Fernando J Martinez; Gary B Huffnagle
Journal:  Annu Rev Physiol       Date:  2015-11-02       Impact factor: 19.318

Review 4.  Lung regeneration: a tale of mice and men.

Authors:  Maria C Basil; Edward E Morrisey
Journal:  Semin Cell Dev Biol       Date:  2019-11-21       Impact factor: 7.727

Review 5.  The role of the microbiome in exacerbations of chronic lung diseases.

Authors:  Robert P Dickson; Fernando J Martinez; Gary B Huffnagle
Journal:  Lancet       Date:  2014-08-23       Impact factor: 79.321

6.  Linking parenchymal disease progression to changes in lung mechanical function by percolation.

Authors:  Jason H T Bates; Gerald S Davis; Arnab Majumdar; Kelly J Butnor; Béla Suki
Journal:  Am J Respir Crit Care Med       Date:  2007-06-15       Impact factor: 21.405

7.  In vivo lung morphometry with hyperpolarized 3He diffusion MRI in canines with induced emphysema: disease progression and comparison with computed tomography.

Authors:  Tariq S K Tanoli; Jason C Woods; Mark S Conradi; Kyongtae Ty Bae; David S Gierada; James C Hogg; Joel D Cooper; Dmitriy A Yablonskiy
Journal:  J Appl Physiol (1985)       Date:  2006-07-27

8.  An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure.

Authors:  Connie C W Hsia; Dallas M Hyde; Matthias Ochs; Ewald R Weibel
Journal:  Am J Respir Crit Care Med       Date:  2010-02-15       Impact factor: 21.405

9.  Quantitative CT characterization of pediatric lung development using routine clinical imaging.

Authors:  Jill M Stein; Laura L Walkup; Alan S Brody; Robert J Fleck; Jason C Woods
Journal:  Pediatr Radiol       Date:  2016-08-30

10.  Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study.

Authors:  Stijn E Verleden; Naoya Tanabe; John E McDonough; Dragoş M Vasilescu; Feng Xu; Wim A Wuyts; Davide Piloni; Laurens De Sadeleer; Stijn Willems; Cindy Mai; Jeroen Hostens; Joel D Cooper; Erik K Verbeken; Johny Verschakelen; Craig J Galban; Dirk E Van Raemdonck; Thomas V Colby; Marc Decramer; Geert M Verleden; Naftali Kaminski; Tillie-Louise Hackett; Bart M Vanaudenaerde; James C Hogg
Journal:  Lancet Respir Med       Date:  2020-02-13       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.